Ultresa and Breastfeeding
It is unclear if Ultresa passes through breast milk. However, it would be quite serious for a woman not to be treated for a pancreatic enzyme deficiency, as it could cause malnutrition. In many cases, the benefits of using Ultresa while breastfeeding outweigh the potential risks to a nursing child. Before using this drug while breastfeeding, discuss the potential risks and benefits with your doctor.
Ultresa® (pancrelipase) is a prescription medication approved for the treatment of pancreatic enzyme deficiencies (such as the type of deficiency that occurs with cystic fibrosis), also known as exocrine pancreatic insufficiency. It is unknown whether Ultresa passes through breast milk in women.
This drug has not been studied in any breastfeeding women or animals, so it is unknown if it passes through breast milk. However, breastfeeding is a time of increased nutritional need for mothers, and it would not be a good time to leave a pancreatic digestive enzyme deficiency untreated, as it could lead to malnutrition. In many cases, the benefits for the breastfeeding woman taking Ultresa would exceed the likely risks to the nursing child.
You should discuss breastfeeding and Ultresa use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.